Raghav Sundar, MD, PhD, National University Cancer Institute, Singapore, Singapore, discusses challenges in integrating AI technologies into clinical workflows. He emphasizes the importance of ensuring good data structure and integration, highlighting the need for robust validation through prospective clinical trials before incorporating AI workflows into routine clinical practices.This interview took place at the 2024 ASCO Gastrointestinal (GI) Cancers Symposium in San Francisco, CA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.